Long-term efficacy of cladribine tablets: Results from the MAGNIFY-MS Extension study
{{output}}
Background: The Phase IV MAGNIFY-MS Extension study evaluated the long-term efficacy and durability of cladribine tablets (CladT) in participants with highly active relapsing multiple sclerosis (RMS) during treatment-free Years (... ...
